Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Inhibition Of RNA Polymerase I Transcription By CX-5461 As a Therapeutic Strategy For The Cancer-Specific Activation Of p53 In Highly Refractory Haematological Malignancies

Nadine Hein, PhD, Sean O'Brien, Ph.D., Denis Drygin, PhD, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, Amit Khot, MD, FRCPath, MBBS, MRCP, Carleen Cullinane, PhD, Matthews Geoff, PhD, Marta Chesi, PhD, Peter Leif Bergsagel, MD, Johannes Zuber, MD, Scott W. Lowe, Ph.D., Ricky W Johnstone, PhD, Rick Pearson, PhD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Ross D Hannan, PhD

Blood (2013) 122 (21): 3941.

https://doi.org/10.1182/blood.V122.21.3941.3941

Published: 2013

Journal Articles

Deregulated Hoxa1 Expression in Murine Bone Marrow Results in An MDS-Like Phenotype

Jean Hendy, BSc, Stewart A Fabb, PhD, Meaghan Wall, MBBS, PhD, FRACP, FRCPA, Lorraine J Gudas, PhD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Louise E Purton, PhD

Blood (2011) 118 (21): 2423.

https://doi.org/10.1182/blood.V118.21.2423.2423

Published: 2011

Journal Articles

Inhibition of RNA Polymerase I Transcription by CX-5461 As a Therapeutic Strategy for the Cancer-Specific Activation of p53 in MLL-Rearranged Acute Myeloid Leukemias

Nadine Hein, PhD, Megan J Bywater, PhD, Kim Stanley, BSc, Inge Verbrugge, PhD, Carlene Cullinane, PhD, Adele Baker, PhD, Hannes Zuber, PhD, Amy Rappaport, PhD, Denis Drygin, PhD, Nanni Huser, PhD, Josh Bliesath, PhD, David M Ryckman, PhD, William G Rice, PhD, Scott W Lowe, PhD, Ricky W Johnstone, PhD, Richard B Pearson, PhD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Ross D Hannan, PhD

Blood (2011) 118 (21): 1548.

https://doi.org/10.1182/blood.V118.21.1548.1548

Published: 2011

Journal Articles

ATRA and the RARα Specific Agonist, NRX195183, Have Opposing Effects on the In Vitro Clonogenicity of Pre-Leukemic Murine AML1-ETO Bone Marrow Cells

Lynette C.Y. Chee, FRACP, FRCPA, MBBS, Jean Hendy, BSc, Louise Purton, PhD, Grant A. McArthur, MD, PhD, FRACP, MBBS

Blood (2010) 116 (21): 999.

https://doi.org/10.1182/blood.V116.21.999.999

Published: 2010

Journal Articles

N-Methyl-2-Pyrrolidone Is a Biologically Active Thalidomide Subunit with In Vivo anti-Myeloma Properties

Jake Shortt, FRACP, FRCPA, Andy Hsu, PhD, Geoffrey M Matthews, PhD, Marta Chesi, P.Leif Bergsagel, MD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Paul Neeson, PhD, David Ritchie, MBBS, FRACP, FRCPA, Ricky W Johnstone, PhD

Blood (2010) 116 (21): 4082.

https://doi.org/10.1182/blood.V116.21.4082.4082

Published: 2010

Journal Articles

Novel Methods for the Sensitive Detection of c- KIT D816V and Other Exon 17 Mutations in Patients with Mastocytosis.

Angela Y. Tan, PhD, David A. Westerman, MD, Kevin P. Lynch, MD, Grant A. McArthur, MD, PhD, Alexander Dobrovic, PhD

Blood (2005) 106 (11): 3273.

https://doi.org/10.1182/blood.V106.11.3273.3273

Published: 2005

NARROW

Inhibition Of RNA Polymerase I Transcription By CX-5461 As a Therapeutic Strategy For The Cancer-Specific Activation Of p53 In Highly Refractory Haematological Malignancies

Deregulated Hoxa1 Expression in Murine Bone Marrow Results in An MDS-Like Phenotype

Inhibition of RNA Polymerase I Transcription by CX-5461 As a Therapeutic Strategy for the Cancer-Specific Activation of p53 in MLL-Rearranged Acute Myeloid Leukemias

ATRA and the RARα Specific Agonist, NRX195183, Have Opposing Effects on the In Vitro Clonogenicity of Pre-Leukemic Murine AML1-ETO Bone Marrow Cells

N-Methyl-2-Pyrrolidone Is a Biologically Active Thalidomide Subunit with In Vivo anti-Myeloma Properties

Novel Methods for the Sensitive Detection of c- KIT D816V and Other Exon 17 Mutations in Patients with Mastocytosis.

Email alerts

ASH Publications

American Society of Hematology

Inhibition Of RNA Polymerase I Transcription By CX-5461 As a Therapeutic Strategy For The Cancer-Specific Activation Of p53 In Highly Refractory Haematological Malignancies

Deregulated Hoxa1 Expression in Murine Bone Marrow Results in An MDS-Like Phenotype

Inhibition of RNA Polymerase I Transcription by CX-5461 As a Therapeutic Strategy for the Cancer-Specific Activation of p53 in MLL-Rearranged Acute Myeloid Leukemias

ATRA and the RARα Specific Agonist, NRX195183, Have Opposing Effects on the In Vitro Clonogenicity of Pre-Leukemic Murine AML1-ETO Bone Marrow Cells

N-Methyl-2-Pyrrolidone Is a Biologically Active Thalidomide Subunit with In Vivo anti-Myeloma Properties

Novel Methods for the Sensitive Detection of c- KIT D816V and Other Exon 17 Mutations in Patients with Mastocytosis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only